Biomedical Engineering Reference
In-Depth Information
9. Linhardt, R. J. Biodegradable polymers for controlled release of drugs. In
Controlled Release
of Drugs
; Rosoff, M., Ed.; VCH Publishers: New York, 1989; pp 53-95.
10. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanopar-
ticles: Theory to Practice.
Pharmacol. Rev.
2001,
53,
283-318.
11. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical
Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties.
Prog. Lipid Res.
2003,
42,
463-478.
12. Yan, X.; Kuipers, F.; Havekes, L. M.; Havinga, R.; Dontje, B.; Poelstra, K.; Scherpof, G. L.;
Kamps, J. A. A.M. The Role of Apolipoprotein E in the Elimination of Liposomes from Blood
by Hepatocytes in the Mouse.
Biochem. Biophys. Res. Commun.
2005,
328,
57-62.
13. Kamps, J. A.; Scherphof, G. L. Receptor versus Non-Receptor Mediated Clearance of
Liposomes.
Adv. Drug Deliv. Rev.
1998,
32,
81-97.
14. Bertholon, I.; Ponchel, G.; Labarre, D.; Couvreur, P.; Vauthier, C. Bioadhesive Properties of
Poly(alkylcyanoacrylate) Nanoparticles Coated with Polysaccharide.
J. Nanosci. Nanotech-
nol.
2006,
6,
3102-3109.
15. Moore, A.; Weissleder, R.; Bogdanov, A., Jr. Uptake of Dextran-Coated Monocrystal-
line Iron Oxides in Tumor Cells and Macrophages.
J. Magn. Reson. Imaging
1997,
7,
1140-1145.
16. Raynal, I.; Prigent, P.; Peyramaure, S.; Najid, A.; Rebuzzi, C.; Corot, C. Macrophage Endocy-
tosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Feru-
moxides and Ferumoxtran-10.
Invest. Radiol.
2004,
39,
56-63.
17. Couvreur, P.; Barratt, G.; Fattal, E.; Legrand, P.; Vauthier, C. Nanocapsule Technology:
A Review.
Crit. Rev. Ther. Drug Carrier Syst.
2002,
19,
99-134.
18. Hume, D. A. The Mononuclear Phagocyte System.
Curr. Opin. Immunol.
2006,
18,
48-53.
19. Muller, R. H.; Maassen, S.; Weyhers, H.; Mehnert, W. Phagocytic Uptake and Cytotoxicity
of Solid Lipid Nanoparticles (Sln) Sterically Stabilized with Poloxamine 908 and Poloxamer
407.
J. Drug Target.
1996,
4,
161-170.
20. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis.
Adv.
Drug Deliv. Rev.
2002,
54,
631-651.
21. Grislain, L.; Couvreur, P.; Lenaerts, V.; Roland, M.; D-Decampeneere, D.; Speiser, P. Phar-
macokinetics and Biodistribution of a Biodegradable Drug-Carrier.
Int. J. Pharm.
1983,
15,
335-345.
22. Bhadra, D.; Bhadra, S.; Jain, P.; Jain, N. K. Pegnology: A Review of PEG-ylated Systems.
Pharmazie
2002,
57,
5-29.
23. Weissleder, R.; Bogdanov, A. J.; Neuwelt, E. A.; Papisov, M. Long-Circulating Iron Oxides
for MR Imaging.
Adv. Drug Deliv. Rev.
1995,
16,
321-334.
24. Park, J. H.; von Maltzhan, G.; Zhang, L.; Schwartz, M. P.; Ruoslahti, E.; Bhatia, S. Magnetic Iron
Oxide Nanoworms for Tumor Targeting and Imaging.
Adv. Mater.
2008,
20,
1630-1635.
25. Bulte, J. W.; Kraitchman, D. L. Iron Oxide MR Contrast Agents for Molecular and Cellular
Imaging.
NMR Biomed.
2004,
17,
484-499.
26. Koo, O. M.; Rubinstein, I.; Onyuksel, H. Role of Nanotechnology in Targeted Drug Delivery
and Imaging: A Concise Review.
Nanomedicine
2005,
1,
193-212.
27. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing
Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors.
Pharmacol. Rev.
1999,
51,
691-743.
28. Au, J. L.; Jang, S. H.; Zheng, J.; Chen, C. T.; Song, S.; Hu, L.; Wientjes, M. G.; Determinants
of Drug Delivery and Transport to Solid Tumors.
J. Contr. Release
2001,
74,
31-46.
29. Fetterly, G. J.; Straubinger, R. M. Pharmacokinetics of Paclitaxel-Containing Liposomes in
Rats.
AAPS PharmSci.
2003,
5,
1-11.
